CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-13 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +123,874 | 123,874 | ||
| 2017-08-31 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +8,155 | $0.26 | $2K | 8,155 |
| 2017-08-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +7,112 | $0.29 | $2K | 7,112 |
| 2017-07-31 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +6,929 | $0.30 | $2K | 6,929 |
| 2017-07-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +6,042 | $0.34 | $2K | 6,042 |
| 2017-06-30 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +4,738 | $0.44 | $2K | 4,738 |
| 2017-06-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +4,738 | $0.44 | $2K | 4,738 |
| 2017-06-15 | Pascale Adam CFO | Grant or award · Options to buy Common Stock | +4,765 | $0.44 | $2K | 4,765 |
| 2017-05-02 | Pascale Adam CFO | Purchase | +15,873 | $0.63 | $10K | 27,389 |
| 2017-02-16 | Pascale Adam CFO | Purchase | +6,981 | $0.46 | $3K | 11,516 |
| 2016-07-29 | Pascale Adam CFO | Grant or award · Incentive Rights | +13,077 | $0.13 | $2K | 13,077 |
| 2016-07-15 | Pascale Adam CFO | Grant or award · Incentive Rights | +14,167 | $0.12 | $2K | 14,167 |
| 2016-06-30 | Pascale Adam CEO | Grant or award · Incentive Rights | +14,167 | $0.12 | $2K | 14,167 |
| 2016-06-21 | Pascale Adam CFO | Grant or award · Options to Buy Common Stock | +150,000 | 150,000 | ||
| 2016-06-15 | Pascale Adam CFO | Grant or award · Incentive Rights | +15,455 | $0.11 | $2K | 15,455 |
| 2016-05-31 | Pascale Adam CFO | Grant or award · Incentive Rights | +14,167 | $0.12 | $2K | 14,167 |
| 2016-05-15 | Pascale Adam CFO | Grant or award · Incentive Rights | +15,455 | $0.11 | $2K | 15,455 |
| 2016-04-30 | Pascale Adam CFO | Grant or award · Incentive Rights | +12,143 | $0.14 | $2K | 12,143 |
| 2016-04-15 | Pascale Adam CFO | Grant or award · Incentive Rights | +12,143 | $0.14 | $2K | 12,143 |
| 2016-03-31 | Pascale Adam CFO | Grant or award · Incentive Rights | +13,077 | $0.13 | $2K | 13,077 |
Page 1 of 2 · 25 trades